99-22150. Memorandum of Understanding Between the Food and Drug Administration and the State of Iowa
[Federal Register Volume 64, Number 165 (Thursday, August 26, 1999)]
[Notices]
[Pages 46688-46693]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-22150]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[FDA 225-99-6002]
Memorandum of Understanding Between the Food and Drug
Administration and the State of Iowa
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is providing notice of
a memorandum of understanding (MOU) between FDA and the State of Iowa.
The purpose of the MOU is to establish policies, procedures, and
responsibilities for the billing and collection of Mammography Quality
Standards Act (MQSA) mammography facility inspection fees for the
second year.
DATES: The agreement became effective July 30, 1999.
FOR FURTHER INFORMATION CONTACT: Lireka P. Joseph, Center for Devices
and Radiological Health (HFZ-200), Food and Drug Administration, 2094
Gaither Rd., Gaithersburg, MD 20850, 301-443-2845.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 20.108(c), which
states that all written agreements and memoranda of understanding
between FDA and others shall be published in the Federal Register, the
agency is publishing notice of this memorandum of understanding.
Dated: August 19, 1999.
William K. Hubbard,
Senior Associate Commissioner for Policy, Planning and Legislation.
BILLING CODE 4160-01-F
[[Page 46689]]
[GRAPHIC] [TIFF OMITTED] TN26AU99.000
[[Page 46690]]
[GRAPHIC] [TIFF OMITTED] TN26AU99.001
[[Page 46691]]
[GRAPHIC] [TIFF OMITTED] TN26AU99.002
[[Page 46692]]
[GRAPHIC] [TIFF OMITTED] TN26AU99.003
[[Page 46693]]
[GRAPHIC] [TIFF OMITTED] TN26AU99.004
[FR Doc. 99-22150 Filed 8-25-99; 8:45 am]
BILLING CODE 4160-01-C
Document Information
- Effective Date:
- 7/30/1999
- Published:
- 08/26/1999
- Department:
- Food and Drug Administration
- Entry Type:
- Notice
- Action:
- Notice.
- Document Number:
- 99-22150
- Dates:
- The agreement became effective July 30, 1999.
- Pages:
- 46688-46693 (6 pages)
- Docket Numbers:
- FDA 225-99-6002
- PDF File:
-
99-22150.pdf